摘要：目的:探讨断藤益母汤(DTYMT)对破骨细胞(Osteoclast,OC)核转录因子κB受体活化因子配体(Receptor Activator...目的:探讨断藤益母汤(DTYMT)对破骨细胞(Osteoclast,OC)核转录因子κB受体活化因子配体(Receptor Activator of Nuclear Factor-kappa B Ligand,RANKL)信号通路及基质金属蛋白酶-9(Matrix Metalloproteinase 9,MMP-9)的影响及其骨保护的作用机制。方法:通过诱导RAW264.7巨噬细胞建立体外破骨细胞显示全部
摘要：<正>Objective:To explore the efficacy of additional short-course of Tocilizumab(TCZ) combined with ...<正>Objective:To explore the efficacy of additional short-course of Tocilizumab(TCZ) combined with csDMARDs in real-world RA management.Methods:Consecutive patients with active RA(DAS28-ESR>2.6) who ha显示全部
